Cover Image
市場調查報告書

細胞腦白質失養症(克拉伯病):全球臨床實驗檢討

Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 308249
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
細胞腦白質失養症(克拉伯病):全球臨床實驗檢討 Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2016
出版日期: 2016年06月30日 內容資訊: 英文 37 Pages
簡介

本報告提供全球主要地區的細胞腦白質失養症(克拉伯病)治療藥臨床實驗數和被實驗人數,各階段趨勢,再彙整主要企業和機關,臨床實驗簡介等。

簡介

  • 細胞腦白質失養症(克拉伯病)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,細胞腦白質失養症(克拉伯病)臨床實驗數量所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,細胞腦白質失養症(克拉伯病)臨床實驗數量所佔的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量 細胞腦白質失養症(克拉伯病)

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

細胞腦白質失養症(克拉伯病)臨床實驗參與的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Zymenex A/S
    • Shire Plc
    • Fate Therapeutics, Inc.
    • Cytomedix, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Masonic Cancer Center
    • University of Rostock
    • Fairview University Medical Center
    • New York Medical College
    • Center for International Blood and Marrow Transplant Research
    • University of Chicago
    • University of Louisville
    • National Center for Research Resourcess
    • National Cancer Institute
    • University of Pittsburgh

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3532CTIDB

GlobalData's clinical trial report, "Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Globoid Cell Leukodystrophy (Krabbe Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Globoid Cell Leukodystrophy (Krabbe Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Region, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Proportion of Globoid Cell Leukodystrophy (Krabbe Disease) to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top